Mutation and control of the human immunodeficiency virus
Related Experiment Video
Updated: Jul 5, 2026

A Restriction Enzyme Based Cloning Method to Assess the In vitro Replication Capacity of HIV-1 Subtype C Gag-MJ4 Chimeric Viruses
Published on: August 31, 2014
1Department of Mechanical and Aerospace Engineering, Princeton University Princeton, P.O. Box CN5263, Princeton, NJ 08544-5263, USA. stengel@princeton.edu
Abstract:
We examine the dynamics of infection by the human immunodeficiency virus (HIV), as well as therapies that minimize viral load, restore adaptive immunity, and use minimal dosage of anti-HIV drugs. Virtual therapies for wild-type infections are demonstrated; however, the HIV infection is never cured, requiring continued treatment to keep the condition in remission. With high viral turnover and mutation rates, drug-resistant strains of HIV evolve quickly. The ability of optimal therapy to contain drug-resistant strains is shown to depend upon the relative fitness of mutant strains.
Related Concept Videos
Viral Mutations
Retrovirus Life Cycles
Sexually Transmitted Infections
Inhibitors of Virion Maturation and Assembly
Immunodeficiency Diseases
There are three main causes of immunodeficiency disorders...
Human Virome

